Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea

被引:36
|
作者
Sato, D [1 ]
机构
[1] Toho Univ Med, Dept Urol 2, Meguro Ku, Tokyo, Japan
关键词
antitumor effect; cancer prevention; catechin; urinary bladder tumors;
D O I
10.1046/j.1442-2042.1999.06239.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Recently, the anticarcinogenic effects of green tea have been studied in sites other than the urinary tract. The present study examined the inhibition by green tea of vesical tumors induced in rats by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN). Methods: In the first series of experiments, 0.05% BBN was added to the drinking water of rats and remained present for 5 weeks. In one experiment, six groups of animals received either tap water, green tea, matcha, hojicha, oolong tea or black tea from week 6. In a second experiment, three groups of rats received either tap water, green tea extract or powdered green tea mixed into a pellet diet from week 6. In a third experiment, five groups of rats were fed a pellet diet with addition of either 0, 0.15, 1.5 or 3.0% powdered green tea from week 6. All rats were killed and examined at 40 weeks. Results: Green tea, particularly green tea leaves, dose-dependently inhibited the growth of BBN-induced urinary bladder rumors when given after the carcinogen. Conclusions: Green tea may inhibit bladder tumor growth.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 50 条
  • [41] INFLUENCE OF DISULFIRAM ON THE METABOLISM OF THE URINARY-BLADDER CARCINOGEN N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE IN THE RAT
    IRVING, CC
    DANIEL, DS
    CARCINOGENESIS, 1987, 8 (09) : 1309 - 1315
  • [42] INHIBITION OF THE OXIDATION OF THE URINARY-BLADDER CARCINOGEN N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE BY PYRAZOLE AND 4-SUBSTITUTED PYRAZOLES
    IRVING, CC
    DANIEL, DS
    BIOCHEMICAL PHARMACOLOGY, 1988, 37 (08) : 1642 - 1644
  • [43] STRAIN DIFFERENCES IN MICE WITH INVASIVE BLADDER CARCINOMAS INDUCED BY N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE
    OHTANI, M
    KAKIZOE, T
    SATO, S
    SUGIMURA, T
    FUKUSHIMA, S
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1986, 112 (02) : 107 - 110
  • [44] HISTOPATHOLOGICAL ANALYSIS OF PRENEOPLASTIC CHANGES DURING N-BUTYL-N-(4-HYDROXYBUTYL)-NITROSAMINE-INDUCED URINARY-BLADDER CARCINOGENESIS IN RATS
    FUKUSHIMA, S
    MURASAKI, G
    HIROSE, M
    NAKANISHI, K
    HASEGAWA, R
    ITO, N
    ACTA PATHOLOGICA JAPONICA, 1982, 32 (02): : 243 - 250
  • [45] p53 gene mutation in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder tumors and N-methyl-N-nitrosourea-induced colon tumors of rats
    Min, HZ
    Kudo, E
    Hino, A
    Yoshimoto, K
    Iwahana, H
    Itakura, M
    Izumi, K
    CANCER LETTERS, 1997, 117 (01) : 81 - 86
  • [46] STAGES OF TRANSFORMATION IN DEVELOPMENT OF N-BUTYL-N-(4-HYDROXYBUTYL)-NITROSAMINE-INDUCED TRANSITIONAL CELL CARCINOMAS IN URINARY-BLADDER OF RATS
    KUNZE, E
    SCHAUER, A
    SCHATT, S
    ZEITSCHRIFT FUR KREBSFORSCHUNG UND KLINISCHE ONKOLOGIE, 1976, 87 (02): : 139 - 160
  • [47] Suppressive Effect of Matrine on Tumor Invasion in N-Butyl-N-(4-Hydroxybutyl)Nitrosamine-Induced Urinary Bladder Carcinogenesis
    Gao, Hua
    Guo, Yafang
    Deng, Ning
    Fei, Pingxia
    Qiu, Xiaofeng
    Zheng, Ping
    Feng, Jun
    Dai, Guidong
    CHEMOTHERAPY, 2014, 60 (02) : 119 - 128
  • [48] A study of antitumor effects of thymosin on rat and mouse urinary bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine
    Wada, S
    Kinoshita, Y
    Kamizuru, M
    Asai, Y
    Iwata, H
    Ikemoto, SI
    Hato, F
    Kishimoto, T
    Fukushima, S
    ONCOLOGY RESEARCH, 1996, 8 (03) : 139 - 144
  • [49] ACTIVATION OF H-RAS ONCOGENE IN RAT BLADDER-TUMORS INDUCED BY N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE
    FUJITA, J
    OHUCHI, N
    ITO, N
    REYNOLDS, SH
    YOSHIDA, O
    NAKAYAMA, H
    KITAMURA, Y
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01) : 37 - 43
  • [50] Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine
    Mitsuhashi, M
    Wanibuchi, H
    Morimura, K
    Doi, K
    Wei, M
    Wada, S
    Nakatani, T
    Fukushima, S
    CANCER SCIENCE, 2003, 94 (12) : 1052 - 1058